HDAC4 Cancer Research Results
HDAC4, Histone deacetylases: Click to Expand ⟱
| Source: |
| Type: |
HDAC4 overexpression is associated with higher tumor grade, advanced clinical stage and poor survival. HDAC4 promotes proliferation and G1/S cell cycle progression in EC cells by inhibiting cyclin-dependent kinase (CDK) inhibitors p21 and p27 and up-regulating CDK2/4 and CDK-dependent Rb phosphorylation.
HDAC4 is often overrepresented and associated with poor prognosis.
HDAC Inhibitors: Given the role of HDAC4 in cancer, HDAC inhibitors (HDACi) are being explored as potential therapeutic agents.
|
Cerv, Cervical Cancer: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
DNMTs↓, DNMT1↓, DNMT3A↓, HDAC2↓, HDAC3↓, HDAC4↓, EZH2↓, PI3K↓, Wnt↓, MAPK↓, hTERT/TERT↓, MMP2↓, MMP7↓, IL6↓, MDM2↓, MMP-10↓, TP53↑, PTEN↑,
Showing Research Papers: 1 to 1 of 1
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1
Pathway results for Effect on Cancer / Diseased Cells:
Cell Death ⓘ
hTERT/TERT↓, 1, MAPK↓, 1, MDM2↓, 1,
Transcription & Epigenetics ⓘ
EZH2↓, 1,
DNA Damage & Repair ⓘ
DNMT1↓, 1, DNMT3A↓, 1, DNMTs↓, 1, TP53↑, 1,
Proliferation, Differentiation & Cell State ⓘ
HDAC2↓, 1, HDAC3↓, 1, HDAC4↓, 1, PI3K↓, 1, PTEN↑, 1, Wnt↓, 1,
Migration ⓘ
MMP-10↓, 1, MMP2↓, 1, MMP7↓, 1,
Immune & Inflammatory Signaling ⓘ
IL6↓, 1,
Clinical Biomarkers ⓘ
EZH2↓, 1, hTERT/TERT↓, 1, IL6↓, 1, TP53↑, 1,
Total Targets: 22
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: HDAC4, Histone deacetylases
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:29 Cells:% prod#:% Target#:407 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page